Correlation Between Denali Therapeutics and Rani Therapeutics
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Rani Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Rani Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Rani Therapeutics Holdings, you can compare the effects of market volatilities on Denali Therapeutics and Rani Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Rani Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Rani Therapeutics.
Diversification Opportunities for Denali Therapeutics and Rani Therapeutics
0.9 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Denali and Rani is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Rani Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rani Therapeutics and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Rani Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rani Therapeutics has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Rani Therapeutics go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Rani Therapeutics
Given the investment horizon of 90 days Denali Therapeutics is expected to generate 0.47 times more return on investment than Rani Therapeutics. However, Denali Therapeutics is 2.14 times less risky than Rani Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Rani Therapeutics Holdings is currently generating about -0.05 per unit of risk. If you would invest 2,512 in Denali Therapeutics on November 2, 2024 and sell it today you would lose (154.00) from holding Denali Therapeutics or give up 6.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Denali Therapeutics vs. Rani Therapeutics Holdings
Performance |
| Timeline |
| Denali Therapeutics |
| Rani Therapeutics |
Denali Therapeutics and Rani Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Denali Therapeutics and Rani Therapeutics
The main advantage of trading using opposite Denali Therapeutics and Rani Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Rani Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rani Therapeutics will offset losses from the drop in Rani Therapeutics' long position.| Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
| Rani Therapeutics vs. Vincerx Pharma | Rani Therapeutics vs. Tenaya Therapeutics | Rani Therapeutics vs. Corvus Pharmaceuticals | Rani Therapeutics vs. Alx Oncology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |